Literature DB >> 31169986

Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study.

Gianpaolo Reboldi1, Paolo Verdecchia2, Francesca Saladini3, Marina Pane1, Lawrence J Beilin4, Kazuo Eguchi5, Yutaka Imai6, Kazuomi Kario5, Takayoshi Ohkubo6,7, Sante D Pierdomenico8, Joseph E Schwartz9,10, Lindon Wing11, Paolo Palatini3.   

Abstract

The prognostic value of uric acid (UA) for cardiovascular events (CVE) is still debated. Our purpose was to investigate the association between UA and CVE in 5243 participants of the ABP-International study with the main aim of identifying optimal sex-specific cut-points. In multivariable Cox analyses, the relationship between CVE and UA as a continuous variable was modeled by including both linear and nonlinear terms. Survival models were also estimated with UA as a categorical variable. Optimal UA cut-points were determined using an outcome-oriented approach. During a median follow-up of 5.9 years, there were 423 CVE (93 fatal). In age- and sex-adjusted Cox models, UA as a continuous variable was a significant predictor of CVE in all individuals and in men and women considered separately. The relationship between UA and CVE was linear (P-value for nonlinearity 0.54 and 0.80 for men and women, respectively). For each 1 mg/dL increase in UA, the relative hazard increase was 16% in men and 19% in women. In fully adjusted models, UA remained a significant predictor of CVE in the whole study cohort. The optimal cut-point best separating patients at low and high risk of CVE was 6.3 mg/dL for men and 4.4 mg/dL for women. Subjects with high UA had a 38% greater risk of CVE. In a sex-specific analysis, the association remained significant only in men (hazard ratio, 1.47; P < 0.01). In conclusion, high UA is an independent predictor for subsequent CVE and significantly improves risk discrimination and reclassification over the baseline multivariable model. ©2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ambulatory; blood pressure; cardiovascular; hypertension; risk; uric acid

Mesh:

Substances:

Year:  2019        PMID: 31169986      PMCID: PMC8030500          DOI: 10.1111/jch.13584

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  40 in total

1.  Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan.

Authors:  Kazufumi Nagahama; Taku Inoue; Kunitoshi Iseki; Takashi Touma; Kozen Kinjo; Yusuke Ohya; Shuichi Takishita
Journal:  Hypertens Res       Date:  2004-11       Impact factor: 3.872

2.  Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study.

Authors:  Michiel J Bos; Peter J Koudstaal; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

3.  Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.

Authors:  Jiunn-Horng Chen; Shao-Yuan Chuang; Hsin-Jen Chen; Wen-Ting Yeh; Wen-Harn Pan
Journal:  Arthritis Rheum       Date:  2009-02-15

4.  Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.

Authors:  Sandip K Zalawadiya; Vikas Veeranna; Sagar Mallikethi-Reddy; Chirag Bavishi; Abhishekh Lunagaria; Anupama Kottam; Luis Afonso
Journal:  Eur J Prev Cardiol       Date:  2014-01-15       Impact factor: 7.804

5.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

6.  Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts.

Authors:  Kazuo Eguchi; Kazuomi Kario; Kazuyuki Shimada
Journal:  Stroke       Date:  2003-09-18       Impact factor: 7.914

7.  Associations of serum uric acid levels with cardiovascular health factors: differences by sex, age and body mass index in Chinese participants.

Authors:  Tingting Du; Xingxing Sun; Huiming Lu; Xuan Lin; Qian Liu; Rui Huo; Xuefeng Yu
Journal:  Eur J Intern Med       Date:  2014-04-01       Impact factor: 4.487

8.  Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis.

Authors:  Weili Zhang; Kai Sun; Ying Yang; Hongye Zhang; Frank B Hu; Rutai Hui
Journal:  Clin Chem       Date:  2009-09-03       Impact factor: 8.327

9.  Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study.

Authors:  Gianpaolo Reboldi; Paolo Verdecchia; Francesca Saladini; Marina Pane; Lawrence J Beilin; Kazuo Eguchi; Yutaka Imai; Kazuomi Kario; Takayoshi Ohkubo; Sante D Pierdomenico; Joseph E Schwartz; Lindon Wing; Paolo Palatini
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

Review 10.  Sex-Specific Relationship Between Serum Uric Acid and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies.

Authors:  Chongke Zhong; Xiaoyan Zhong; Tian Xu; Tan Xu; Yonghong Zhang
Journal:  J Am Heart Assoc       Date:  2017-03-29       Impact factor: 5.501

View more
  4 in total

1.  Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study.

Authors:  Gianpaolo Reboldi; Paolo Verdecchia; Francesca Saladini; Marina Pane; Lawrence J Beilin; Kazuo Eguchi; Yutaka Imai; Kazuomi Kario; Takayoshi Ohkubo; Sante D Pierdomenico; Joseph E Schwartz; Lindon Wing; Paolo Palatini
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

2.  Which serum uric acid levels are associated with increased cardiovascular risk in the general adult population?

Authors:  Alena Krajčoviechová; Peter Wohlfahrt; Jan Bruthans; Pavel Šulc; Věra Lánská; Lenka Eremiášová; Jan Pudil; Aleš Linhart; Jan Filipovský; Otto Mayer; Jiří Widimský; Milan Blaha; Claudio Borghi; Renata Cífková
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

3.  Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study.

Authors:  Edoardo Casiglia; Valérie Tikhonoff; Agostino Virdis; Stefano Masi; Carlo M Barbagallo; Michele Bombelli; Bernardino Bruno; Arrigo F G Cicero; Massimo Cirillo; Pietro Cirillo; Giovambattista Desideri; Lanfranco D'Elia; Claudio Ferri; Ferruccio Galletti; Loreto Gesualdo; Cristina Giannattasio; Guido Iaccarino; Luciano Lippa; Francesca Mallamaci; Alessandro Maloberti; Alberto Mazza; Maria Lorenza Muiesan; Pietro Nazzaro; Paolo Palatini; Gianfranco Parati; Roberto Pontremoli; Fosca Quarti-Trevano; Marcello Rattazzi; Giulia Rivasi; Massimo Salvetti; Giuliano Tocci; Andrea Ungar; Paolo Verdecchia; Francesca Viazzi; Massimo Volpe; Guido Grassi; Claudio Borghi
Journal:  J Hypertens       Date:  2020-03       Impact factor: 4.776

4.  Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.

Authors:  Takeo Ishii; Tomohiro Kumagae; Hiromichi Wakui; Shingo Urate; Shohei Tanaka; Eriko Abe; Toru Suzuki; Takahiro Yamaji; Sho Kinguchi; Ryu Kobayashi; Kotaro Haruhara; Takashi Nakamura; Shuzo Kobayashi; Kouichi Tamura
Journal:  FEBS Open Bio       Date:  2021-02-01       Impact factor: 2.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.